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Abstract
Introduction: Although mitochondrial dysfunction is proposed to be involved in the pathophysiology of sepsis,
conflicting results are reported. Variation in methods used to assess mitochondrial function might contribute to
this controversy. A non-invasive method for monitoring mitochondrial function might help overcome this
limitation. Therefore, this study explores the possibility of in vivo monitoring of mitochondrial oxygen tension
(mitoPO2) and local mitochondrial oxygen consumptionin in an endotoxin-induced septic animal model.
Methods: Animals (rats n = 28) were assigned to a control group (no treatment), or to receive lipopolysaccharide
without fluid resuscitation (LPS-NR) or lipopolysaccharide plus fluid resuscitation (LPS-FR). Sepsis was induced by
intravenous LPS injection (1.6 mg/kg during 10 min), fluid resuscitation was performed by continuous infusion
of a colloid solution, 7 ml kg−1 h−1 and a 2-ml bolus of the same colloid solution. MitoPO2 and ODR were
measured by means of the protoporphyrin IX-triplet state lifetime technique (PpIX-TSLT). Kinetic aspects of the
drop in mitoPO2 were recorded during 60s of skin compression. ODR was derived from the slope of the mitoPO2
oxygen disappearance curve. Measurements were made before and 3 h after induction of sepsis.
Results: At baseline (t0) all rats were hemodynamically stable. After LPS induction (t1), significant (p < 0.05)
hemodynamic changes were observed in both LPS groups. At t0, mitoPO2 and ODR were 59 ± 1 mmHg,
64 ± 3 mmHg, 68 ± 4 mmHg and 5.0 ± 0.3 mmHg s−1, 5.3 ± 0.5 mmHg s−1, 5.7 ± 0.5 mmHg s−1 in the control,
LPS-FR and LPS-NR groups, respectively; at t1 these values were 58 ± 5 mmHg, 50 ± 2.3 mmHg, 30 ± 3.3 mmHg and
4.5 ± 0.5 mmHg s−1, 3.3 ± 0.3 mmHg s−1, 1.8 ± 0.3 mmHg s−1, respectively. At t1, only mitoPO2 showed a significant
difference between the controls and LPS-NR. In contrast, at t1 both LPS groups showed a significantly lower ODR
compared to controls.
Conclusion: These data show the feasibility to monitor alterations in mitochondrial oxygen consumption in vivo by
PpIX-TSLT in a septic rat model. These results may contribute to the development of a clinical device to monitor
mitochondrial function in the critically ill.
Introduction
Sepsis and septic shock are life-threatening disorders
with a high mortality rate of 30–60 % [1]. The pathophysi-
ology of sepsis is multifactorial and complex. Conse-
quently, the treatment of severe sepsis and septic shock
requires extensive knowledge and often reaches the limits
of possibilities in the ICU. Part of the current treatment
for sepsis is aimed at safeguarding or restoring oxygen
supply to tissue cells by early aggressive administration of
intravenous fluids, and the use of inotropic and vasoactive
agents. Early aggressive resuscitation in sepsis is known to
modulate inflammation [2] and improve microvascular
perfusion [3], even though the clinical outcome is not al-
ways improved [4–6]. The management of sepsis therefore
remains a challenge despite advances in both monitoring
and treatment.
Mitochondrial dysfunction is suggested to be a key
issue in the pathophysiology of and recovery from sepsis
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[7, 8]. In the case of mitochondrial dysfunction, opti-
mization of the macrocirculation and microcirculation
alone is not likely to result in improved aerobic cell me-
tabolism. This might explain why treatment focused on
adequate tissue perfusion and oxygenation does not
always lead to a better prognosis. Despite many studies
on the role of mitochondrial dysfunction in sepsis over
the last 40 years, clear evidence for the underlying
mechanism is still lacking [9]. Whereas some authors
report decreased mitochondrial oxygen consumption in
sepsis [9–13], others found an unchanged [14] or even
improved [15, 16] mitochondrial function under similar
circumstances.
Most knowledge on mitochondrial dysfunction in sep-
sis is derived from animal experiments using isolated
cells or mitochondria from tissue biopsies [8, 10, 17],
providing detailed insight into the function of the re-
spiratory chain. However, measurements in isolated
mitochondria may not reflect the in vivo situation. This
is due to the possible loss of essential metabolites during
mitochondrial isolation and disruption of the normal in-
teractions of the organelle with the cytoskeleton [18], a
situation that is partly solved by applying respirometry
on homogenates or permeabilized cells. However, such
ex vivo measurements pose experimental limitations that
may partly explain the controversial reports on mito-
chondrial dysfunction in sepsis [9]. In addition, the use
of different methods to measure mitochondrial oxygen
consumption, different models of sepsis, a long or short
duration of sepsis, and different target organs may also
contribute to the lack of a clear pattern [19]. Therefore,
in their review, Jeger et al. [9] concluded that “… in
order to get a better understanding about mitochon-
drial dysfunction in sepsis a valid non-invasive method
to monitor mitochondrial function in vivo would be
necessary”.
A method developed to measure the mitochondrial
oxygen tension (mitoPO2) using the protoporphyrin
IX-triplet state lifetime technique (PpIX-TSLT) [20, 21]
provides new opportunities to monitor mitochondrial
function in vivo. The PpIX-TSLT enables mitoPO2 mea-
surements by means of the oxygen-dependent optical
properties of 5-aminolevulinic acid (ALA)-induced en-
dogenous protoporphyrin IX (PpIX). Our group investi-
gates mitochondrial respirometry with the aim to monitor
mitoPO2 and local mitochondrial oxygen consumption
measured by the oxygen disappearance rate (ODR) in
skin [22–24]. The PpIX-TSLT is the first technique to
allow measurement of the mitoPO2 in living cells,
and can also be applied in vivo [21, 25]. Moreover,
because this technique is noninvasive and safe for ap-
plication in humans [26], the PpIX-TSLT may enable
clinical monitoring of mitochondrial function at the
cellular level.
The present study explores the possibility to moni-
tor in vivo the mitoPO2 and ODR in an animal
model of acute critical illness. We report on the use of
the PpIX-TSLT for cutaneous respirometry in healthy rats
compared with rats with endotoxin-induced sepsis.
Methods
Principle of mitoPO2 measurements
The background of the PpIX-TSLT is described in detail
elsewhere [20–22, 24]. In short, PpIX is the final precur-
sor of heme in the heme biosynthetic pathway. PpIX is
synthesized in the mitochondria, and administration
of ALA substantially enhances the PpIX concentration.
Since the conversion of PpIX to heme is a rate-limiting
step, administration of ALA causes accumulation of PpIX
inside the mitochondria (Fig. 1). PpIX possesses a triplet
state that reacts strongly with oxygen, making its lifetime
oxygen dependent. Population of the first excited triplet
state occurs upon photoexcitation with a pulse of light,
and causes the emission of red delayed fluorescence. The
delayed fluorescence lifetime is related to the mitoPO2 ac-








in which τ is the measured delayed fluorescence lifetime,
kq is the quenching constant, and τ0 is the lifetime at
zero oxygen. In the case of a nonhomogeneous oxygen
distribution inside the measurement volume, a reliable
estimation of the average PO2 can be made by the rect-
angular distribution method (RDM) [27, 28].
Delayed luminescence setup
A compact computer-controlled tunable laser (Opolette
355-I; Opotek, Carlsbad, CA, USA), providing pulses
with a specified duration of 4–10 nanoseconds and
typically 2–4 mJ/pulse over the tunable range of 410–
670 nm, was used as excitation source. The laser was
coupled into a Fiber Delivery System (Opotek) consist-
ing of a 50 mm planoconvex lens, an X–Y fiber mount,
and a 2 m fiber with a core diameter of 1000 μm. This
fiber was coupled to a custom-made reflection probe by
an In-Line Fiber Optic Attenuator (FOA-Inline; Avantes
b.v., Eerbeek, the Netherlands). The reflection probe
consisted of two 1000 μm fibers with a length of 2 m
(P1000-2-VIS-NIR; Ocean Optics, Dunedin, FL, USA)
mounted at the common end into a stainless steel holder
with a separation of 1 mm between the fibers. The com-
mon end of the reflection probe consisted of an
aluminum rod with a length of 5 cm and a diameter of
10 mm. The light output of the excitation branch was
measured by a FieldMate laser power meter with a
PowerMax PS19 measuring head (Coherent Inc., Santa
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Clara, CA, USA). Our experiments used an excitation
energy of 250 μJ/pulse and a repetition frequency of
1 Hz. The PpIX signal was detected by a gated micro-
channel plate photomultiplier tube (MCP-PMT R5916U
series; Hamamatsu Photonics, Hamamatsu, Japan). The
emission branch of the reflection probe was fit into an
Oriel Fiber Bundle Focusing Assembly (Model 77799;
Newport, Irvine, CA, USA) which was coupled to the
MCP-PMT by an in-house built optics consisting of a fil-
ter-holder, a plano convex lens (BK-7; OptoSigma, Santa
Ana, CA, USA) with focal length of 90 mm, and an elec-
tronic shutter (04 UTS 203; Melles Griot, Albuquerque,
NM, USA). The PpIX emission light was filtered by a
combination of a 590 nm longpass filter (OG590;
Newport) and a broadband (675–25 nm) bandpass filter
(Omega Optical, Brattleboro, VT, USA).
Principle of the local oxygen consumption measurements
The local oxygen consumption is measured by the ODR
after local cessation of the oxygen supply by pressure-
induced occlusion of the microcirculation. The reflection
probe was mounted above the ALA cream-treated skin
with a height-adjustable stand, allowing different settings
for the probe-to-skin distance. Occlusion of the micro-
circulation in the skin was obtained by local pressure
with the measurement probe. This simple procedure
reliably created stop-flow conditions and induced a
measurable ODR, due to cessation of the microvascular
oxygen supply and ongoing cellular oxygen consump-
tion. The mitoPO2 was measured before and during
application of pressure at an interval of 1 Hz, using one
laser pulse per measurement. The principles of ODR
measurements are shown in Fig. 2. We have described
these principles in detail and provided a working im-
plementation of the technique for ODR measurements
previously [26]. In that implementation, we developed a
method for the analysis of delayed-fluorescence-based
ODR data to calculate the mitoPO2, ODR, and P50 and
demonstrated the feasibility and reproducibility of our
method in rats [26].
Animal preparation
The protocol was approved by the Animal Research
Committee of the Erasmus University Medical Center
Rotterdam, the Netherlands. Animal care and handling
were performed in accordance with the guidelines for
Institutional and Animal Care and Use Committees.
A total of 28 male Wistar rats (mean body weight 292 g,
standard deviation ± 25.5 g) were used in this study. All
animals were anesthetized by intraperitoneal injection of a
mixture of ketamine 90 mg/kg (Alfasan, Woerden, the
Netherlands), 0.5 mg/kg medetomidine (Sedator Eurovet
Animal Health BV, Bladel, the Netherlands), and 0.05 mg/
kg atropine (Centrofarm Services BV, Etten-Leur, the
Netherlands). Ketamine (50 mg/kg/hour) and crystalloid
solution (Ringer’s lactate, 5 ml/kg/hour) were infused
intravenously to maintain anesthesia and fluid balance.
Following tracheotomy, mechanical ventilation was insti-
gated (Babylog 8000 plus; Dräger, Lubeck, Germany).
Ventilation was adjusted on end-tidal carbon dioxide
tension, keeping the arterial carbon dioxide tension at
35–45 mmHg. The inspired oxygen concentration was
set at 40 %. A polyethylene catheter (outer diameter
0.9 mm) was inserted into the right jugular vein for intra-
venous administration of a colloid solution (Voluven
3.5 ml/kg/hour). Arterial blood pressure and heart rate
Fig. 1 a Principle of the PpIX-TSLT. The pathway by which topical ALA administration enhances mitochondrial PpIX levels and the principle
of delayed fluorescence detection after an excitation pulse with green (510 nm) light. Emission light is the delayed fluorescence (red light,
630–700 nm) and its lifetime is oxygen dependent. b PpIX emits delayed fluorescence after excitation by a pulse of green (510 nm) light. The
delayed fluorescence lifetime is oxygen dependent according to the Stern–Volmer equation (inset), in which kq is the quenching constant and τ0
is the lifetime at zero oxygen. ALA 5-aminolevulinic acid, CPIII coporporphyrinogen III, PBG porphobilinogen, PO2 oxygen tension, PpIX protoporphyrin
IX, UPIII urporphyrinogen III
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were monitored with a similar catheter in the left femoral
artery. Every hour we performed analysis of arterial blood
gas, and measured cardiac output by thermodilution
(PowerLab; ADInstruments, Colorado Springs, CO, USA)
with the thermistor inserted in the right carotid artery.
Body temperature was rectally measured and maintained
at 38 ± 0.5 °C by means of a heating pad.
Experimental setup
In all groups PpIX was induced by topical application of
2.5 % ALA cream. The ALA cream was prepared by
mixing hydrophilic cremor lanette (Lanettecreme I FNA;
Bipharma, Weesp, the Netherlands) and 2.5 % ALA
(Sigma-Aldrich, St. Louis, MO, USA) just before use.
The cream was topically administered on the abdominal
skin after hair removal. The latter was accomplished by
shaving and subsequent use of hair removal cream
(Veet; Reckitt Benckiser Co., Slough, UK). The ALA-
treated skin was covered with an adhesive film to avoid
evaporation. Furthermore, to prevent premature exposure
of the primed skin to light, the primed area was covered
with aluminum foil. After 3 hours, sufficient PpIX had
accumulated to commence baseline (t0) in vivo measure-
ments of the mitoPO2 and ODR. All mitoPO2 and ODR
measurements were performed in a dark environment to
prevent ambient light contamination.
After measurements at t0, animals were assigned to
one of three groups: lipopolysaccharide without fluid
resuscitation (LPS-NR, n = 10), LPS with fluid resus-
citation (LPS-FR, n = 10), and untreated control (n = 8).
The LPS groups received an intravenous LPS injection
(1.6 mg/kg during 10 minutes) (extracted from Escheri-
chia coli, serotype 0127:B8; Sigma-Aldrich). The LPS
was dissolved at a concentration of 1 mg/ml in a crystal-
loid solution. The oxygen measurements were repeated
3 h after infusion of LPS (t1).
In the LPS-FR group, fluid resuscitation was achieved
by continuous infusion of a colloid solution at 7 ml/kg/
hour (Voluven; Fresenius Kabi, Bad Homburg, Germany);
a 2 ml bolus of the same colloid solution was administered
just before the start of the t2 measurements. Finally, in the
LPS-NR group a 2 ml colloid fluid bolus (Voluven; Frese-
nius Kabi) was given directly after t1 measurements to
achieve a late resuscitation model (LPS-LR). The effect of
this late resuscitation on the mitoPO2 and ODR was
measured directly after fluid administration (t2). Figure 3
describes the experimental setup.
Statistical analysis
Statistical analyses were performed using IBM SPSS ver-
sion 21 (IBM Corporation, Armonk, NY, USA). Unless
stated otherwise, all values are reported as mean ± stand-
ard error.
Statistical significance between groups was calcu-
lated using a two-tailed Student's t test. A paired Stu-
dent’s t test was used to compare differences between
Fig. 2 Principles of respirometry in the skin by oxygen-dependent quenching of delayed fluorescence of PpIX. a Baseline measurement. b Principle of
the pressure-induced cessation of microvascular blood flow. Vm measurement volume
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measurements at t0 and t1. p ≤0.05 was considered
statistically significant.
Results
Delayed fluorescence signals were easily detected 3 hours
after induction with topically applied ALA. Table 1 pre-
sents data on the hemodynamic parameters of the ex-
perimental groups. At the t0 measurement, all rats were
hemodynamically stable without signs of hypoperfusion
(reflected by low serum lactate) and there were no sig-
nificant differences between the groups. At t1, significant
(p <0.05) changes in hemodynamics were observed in
both LPS groups. In the LPS-FR group macrohemody-
namic parameters were preserved by means of fluid re-
suscitation, indicated by unchanged mean arterial blood
pressure and cardiac output. In contrast, macrohemody-
namic parameters were compromised in the LPS-NR
group. Both LPS groups showed significant metabolic
acidosis with increased serum lactate.
Table 2 presents data on the mitoPO2 and ODR. Both
parameters showed a significant decrease in the LPS-NR
induced septic group, whereas no differences were ob-
served in the control group. In the LPS-FR group, no
differences in mitoPO2 were observed compared with
the control group. However, in spite of normal mitoPO2
values, there was a significantly decreased ODR in the
LPS-FR group. At t1 in the LPS-NR group, both the
mitoPO2 and ODR were significantly lower compared
with values at t0. Figure 4 presents a representative ex-
ample of mitochondrial consumption measurements
under normal conditions (Fig. 4a) and under septic con-
ditions without resuscitation (Fig. 4b).
Figure 5 shows mitoPO2 and ODR measurements in
the LPS-NR group measured at baseline (t0), during septic
conditions without fluid resuscitation (t1), and immedi-
ately after a late fluid resuscitation (t2) with a bolus of col-
loid. The mitoPO2 values measured before the stop-flow
situation were generally around 65 mmHg; induction of
sepsis resulted in hemodynamic changes, with a corre-
sponding decrease in mitoPO2 to values around 30 mmHg.
The mitoPO2 recovered to baseline values after late resus-
citation with a fluid bolus. Before late resuscitation, the
decreased ODR might be a consequence of the persisting
hypoperfusion resulting in low mitoPO2 values. Interest-
ingly, however, recovery of the mitoPO2 values by fluid
resuscitation in the LPS-LR group also failed to result in
normalization of ODR.
Discussion
In this acute model of LPS-induced sepsis in rats, our
results support the idea that mitochondrial dysfunction
contributes to the pathophysiology of sepsis, even in the
absence of severe hemodynamic shock and diminished
mitochondrial oxygenation. We found reduced cellular
oxygen consumption after restoring tissue oxygenation
to baseline levels with fluid resuscitation. Reduced mito-
chondrial respiration in the absence of hypoxia clearly
indicates a hampered aerobic metabolism. Importantly,
these measurements were made on the cellular level in
vivo, thereby eliminating the potential bias introduced
by more invasive and destructive techniques such as
mitochondrial isolation.
As expected in an animal model of induced sepsis, our
endotoxemic rats were hemodynamically compromised
Fig. 3 Schematic flow chart of the experimental setup. ALA 5-aminolevulinic acid, LPS lipopolysaccharide, PpIX protoporphyrin IX
Harms et al. Critical Care  (2015) 19:343 Page 5 of 9
Table 2 mitoPO2 and ODR before and after LPS induction
Parameter Baseline measurements (t0) Measurements 3 hours after LPS infusion (t1)
Control group (n = 8)
mitoPO2 (mmHg) 59 ± 1 58 ± 5
ODR (mmHg/second) 5.0 ± 0.3 4.5 ± 0.5
Baseline measurements (t0) Post-LPS measurements (t1)
LPS resuscitation group (n = 10)
mitoPO2 (mmHg) 64 ± 3.0 50 ± 2.3
*
ODR (mmHg/second) 5.3 ± 0.5 3.3 ± 0.3*†
Baseline measurements (t0) Post-LPS measurements (t1)
LPS nonresuscitation group (n = 10)
mitoPO2 (mmHg) 68 ± 4
† 30 ± 3.3*†
ODR (mmHg/second) 5.7 ± 0.51 1.8 ± 0.3*†
Data presented as mean ± standard error
*Significant difference (p <0.05) compared with baseline measurements
†Significant difference (p <0.05) compared with control group
LPS lipopolysaccharide, mitoPO2 mitochondrial oxygen tension, ODR oxygen disappearance rate
Table 1 Hemodynamic parameters
Parameter Baseline measurements (t0) Measurements 3 hours after
LPS infusion (t1)
Measurements after late resuscitation (t2)
Control group (n = 8)
Cardiac output (ml/minute) 137 ± 21 115 ± 32
Mean arterial pressure (mmHg) 78 ± 4 66 ± 3*
Heart rate (bpm) 235 ± 12 244 ± 12
pH 7.33 ± 0.01 7.28 ± 0.04
pCO2 (mmHg) 39 ± 1.8 36 ± 2.0
pO2 (mmHg) 201 ± 3.99 201 ± 6.64
Baseline measurements (t0) Post-LPS measurements (t1)
LPS resuscitation group (n = 10)
Cardiac output (ml/minute) 118 ± 28 111 ± 36
Mean arterial pressure (mmHg) 82 ± 3 80 ± 8
Heart rate (bpm) 240 ± 7 292 ± 14*†
pH 7.34 ± 0.01 7.16 ± 0.02*†
pCO2 (mmHg) 36 ± 2 38.5 ± 2
pO2 (mmHg) 196 ± 5 209 ± 3
*
Lactate (mmol/l) 1.10 ± 0.07 3.87 ± 0.32*†
Baseline measurements (t0) Post-LPS measurements (t1) Late resuscitation measurements (t2)
LPS non-resuscitation group (n = 10)
Cardiac output (ml/minute) 135 ± 17 50 ± 19* 343 ± 80*†
Mean arterial pressure (mmHg) 76 ± 9 57 ± 4 53 ± 4
Heart rate (bpm) 247 ± 10 268 ± 29 294 ± 14
pH 7.35 ± 0.01 7.14 ± 0.01*† 7.12 ± 0.01*†
pCO2 (mmHg) 35 ± 2 37 ± 2 34 ± 3
pO2 (mmHg) 192 ± 3 189 ± 7 193 ± 8
Lactate (mmol/l) 1.38 ± 0.10 4.30 ± 0.33*† 5.00 ± 0.77*†
Data presented as mean ± standard error
*Significantly different (p <0.05) compared with baseline measurements
†Significantly difference (p <0.05) compared with control group
LPS lipopolysaccharide, PCO2 carbon dioxide tension, PO2 oxygen tension
Harms et al. Critical Care  (2015) 19:343 Page 6 of 9
with a low mean arterial pressure and cardiac output.
Septic rats also showed high lactate levels and low pH
levels, and signs of metabolic acidosis, suggesting a
possible increase in anaerobic metabolism. However,
while the induction of sepsis without fluid resuscitation
resulted in a clear decrease in both the mitoPO2 and
ODR, fluid resuscitation resulted in other changes. Early
fluid resuscitation, given to avoid the development of
tissue hypoperfusion, resulted in a decreased ODR while
the mitoPO2 remained almost unchanged compared with
the control group. Furthermore, late resuscitation by a
fluid bolus almost completely restored the mitoPO2 to
baseline values. However, in contrast to the idea that
decreased oxygen consumption is secondary to tissue hyp-
oxia, the ODR did not recover after fluid resuscitation.
An impaired ODR, despite a normal mitoPO2, sug-
gests persisting mitochondrial dysfunction in the endo-
toxemic animals. Administration of LPS in rats is known
to induce complex I inhibition of the mitochondrial
respiratory chain in the heart, liver and diaphragm
[14, 29–31]. The present findings are probably based
on the same principles and are likely to reflect the in
vivo situation of this phenomenon. However, obviously
some care should be taken with such a mechanistic inter-
pretation of our results. Also, since the mitoPO2 reflects
the balance between local oxygen supply and demand
[26], a decrease in the ODR could be expected to result in
an increase in the mitoPO2. Since we did not measure
microvascular blood flow we can only speculate on why
we did not observe such a phenomenon. Vascular auto-
regulation normally matches blood flow to metabolism,
and under baseline conditions mitoPO2 measurements
are indeed highly reproducible. In the absence of vascular
autoregulation, a high cardiac output in combination with
a reduced ODR (the situation after late resuscitation)
could indeed be expected to lead to an increased mitoPO2
compared with baseline. The fact that the mitoPO2 more
or less restores to baseline values suggests that in our
model the autoregulation in the cutaneous microcircula-
tion is not (yet) severely compromised.
In addition to these findings, our results demonstrate
that the PpIX-TSLT enables monitoring of the mitochon-
drial function in skin. The technique provides in vivo
information on oxygenation and oxygen consumption of
the mitochondria, without the need to damage tissue
for isolation of mitochondria. Therefore, our method
overcomes some of the disadvantages of earlier stud-
ies on mitochondrial dysfunction in sepsis. Because the
PpIX-TSLT can be applied in humans, the technique is po-
tentially feasible for clinical monitoring [32]. Although our
Fig. 4 Representative example of mitochondrial oxygen consumption measurement in a rat from the nonresuscitation group. a Before
administration of LPS. b Three hours after administration of LPS. LPS lipopolysaccharide, mitoPO2 mitochondrial oxygen tension, ODR oxygen
disappearance rate
Fig. 5 Average mitoPO2 and ODR in the nonresuscitation group
at three time points: baseline (t0) before the induction of sepsis,
3 hours after LPS infusion (t1), and after late fluid resuscitation (t2).
Data presented as mean ± standard error. *Significant difference
compared with baseline measurements (p <0.05). LPS lipopolysaccharide,
mitoPO2 mitochondrial oxygen tension, ODR mitochondrial
oxygen consumption
Harms et al. Critical Care  (2015) 19:343 Page 7 of 9
implementation of the PpIX-TSLT is an important step to-
wards addressing the need for a valid noninvasive method
to monitor mitochondrial function in vivo, as proposed by
Jeger et al. [9], some questions still remain. The clinical
relevance of our method needs additional studies which,
for example, investigate the correlation between mito-
chondrial function in the skin and other organs.
It is important to note that with the PpIX-TSLT we
can measure relatively high mitoPO2 values in the skin.
In fact, the mitoPO2 appears to be in the same range as
the intracutaneous oxygen tension measured by micro
oxygen electrode measurements [33, 34]. Since oxygen
transport into tissue cells is driven by a diffusion gradient,
one would expect mitoPO2 to be lower, so our data are
surprising and somewhat controversial. Unfortunately, a
noninvasive gold standard for measuring (intra)cutaneous
oxygen tension is lacking. Although the PpIX-TSLT is
quantitative and calibrated, the interpretation of the data
assumes exclusive mitochondrial localization of the PpIX,
which owing to technical limitations has not been conclu-
sively verified to date. Important in this respect is that we
did not see delayed fluorescence in full blood and plasma,
arguing against intravascular localization of PpIX as a rea-
son for high mitoPO2 readings. Furthermore, the PpIX-
TSLT shares the property of other lifetime techniques in
that it becomes less accurate for shorter lifetimes. The
mitoPO2 measurements therefore become less robust at
higher oxygen tensions. Although our data clearly demon-
strate that the PpIX-TSLT is a valuable addition to the ar-
senal of in vivo oxygen measurements, further evaluation
of this novel technique is needed and ongoing. The reader
should bear these considerations in mind while interpret-
ing the absolute values of the measurements.
Conclusions
This study shows the feasibility to measure mitochondrial
oxygenation and oxygen consumption in endotoxemic
rats by means of a cutaneous PpIX-TSLT. A decreased
local oxygen consumption in the presence of preserved or
restored mitoPO2 suggests that mitochondrial dysfunction
contributes to the metabolic failure in sepsis, even in the
absence of hemodynamic shock. These results are promis-
ing in view of our aim to develop a clinical mitochondrial
monitoring technique. Clinical implementation of this
technique is likely to contribute to our understanding of
mitochondrial dysfunction in sepsis and the development
of therapeutic approaches aimed at restoring aerobic me-
tabolism and cellular function.
Key messages
 The PpIX-TSLT is able to measure mitochondrial
oxygenation and oxygen consumption in
endotoxemic rats
 The PpIX-TSLT is able to measure changes in
mitochondrial oxygenation and oxygen consumption
due to the induction of endotoxemia
 The data from this study suggest that mitochondrial
dysfunction contributes to the metabolic failure in
sepsis
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